Bone mass in rett syndrome: Association with clinical parameters and MECP2 mutations

Jay Shapiro, Genila M Bibat, Girish Hiremath, Mary E Blue, Shilpa Hundalani, Theodore Yablonski, Aditi Kantipuly, Charles A Rohde, Michael V Johnston, Sakkubai Naidu

Research output: Contribution to journalArticle

Abstract

Rett syndrome (RTT) is an X-linked neurodevelopmental disorder caused by mutations in the MECP2 gene. In 49 female RTT children, aged 1.9-17 y, bone mass was assessed and correlated with clinical parameters and mutations involving the MECP2 gene. We also studied five adult females, aged 20-33 y, and one male child, aged 6 y. Lumbar spine bone mineral content (BMC) and bone mineral density (BMD) were correlated with weight, height, BMI, clinical severity, degree of scoliosis, use of anticonvulsants, and ambulatory status. L1-L4 BMD and BMC showed that 48.9% of them had BMD values >2 SD below age-related norms. BMD values were in the osteoporotic range in the five adult females with RTT. Eleven percent of the children and adults with RTT experienced fractures. Low bone mass was correlated with marginal significance to clinical severity and ambulation but not to scoliosis or anticonvulsant use. Lowest bone mass occurred in patients with T158M or R270X mutations but without statistical significance. Studies in a murine model of RTT confirmed low bone mass as an inherent component of this syndrome. MECP2 mutations and clinical parameters impact bone mass in RTT, but an association with a specific mutation was not demonstrable.

Original languageEnglish (US)
Pages (from-to)446-451
Number of pages6
JournalPediatric Research
Volume68
Issue number5
DOIs
StatePublished - Nov 2010

Fingerprint

Rett Syndrome
Bone Density
Bone and Bones
Mutation
Scoliosis
Anticonvulsants
Genes
Walking
Spine
Weights and Measures

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Bone mass in rett syndrome : Association with clinical parameters and MECP2 mutations. / Shapiro, Jay; Bibat, Genila M; Hiremath, Girish; Blue, Mary E; Hundalani, Shilpa; Yablonski, Theodore; Kantipuly, Aditi; Rohde, Charles A; Johnston, Michael V; Naidu, Sakkubai.

In: Pediatric Research, Vol. 68, No. 5, 11.2010, p. 446-451.

Research output: Contribution to journalArticle

@article{1cba8a247ee14ecdbf69cad5688654be,
title = "Bone mass in rett syndrome: Association with clinical parameters and MECP2 mutations",
abstract = "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder caused by mutations in the MECP2 gene. In 49 female RTT children, aged 1.9-17 y, bone mass was assessed and correlated with clinical parameters and mutations involving the MECP2 gene. We also studied five adult females, aged 20-33 y, and one male child, aged 6 y. Lumbar spine bone mineral content (BMC) and bone mineral density (BMD) were correlated with weight, height, BMI, clinical severity, degree of scoliosis, use of anticonvulsants, and ambulatory status. L1-L4 BMD and BMC showed that 48.9{\%} of them had BMD values >2 SD below age-related norms. BMD values were in the osteoporotic range in the five adult females with RTT. Eleven percent of the children and adults with RTT experienced fractures. Low bone mass was correlated with marginal significance to clinical severity and ambulation but not to scoliosis or anticonvulsant use. Lowest bone mass occurred in patients with T158M or R270X mutations but without statistical significance. Studies in a murine model of RTT confirmed low bone mass as an inherent component of this syndrome. MECP2 mutations and clinical parameters impact bone mass in RTT, but an association with a specific mutation was not demonstrable.",
author = "Jay Shapiro and Bibat, {Genila M} and Girish Hiremath and Blue, {Mary E} and Shilpa Hundalani and Theodore Yablonski and Aditi Kantipuly and Rohde, {Charles A} and Johnston, {Michael V} and Sakkubai Naidu",
year = "2010",
month = "11",
doi = "10.1203/PDR.0b013e3181f2edd2",
language = "English (US)",
volume = "68",
pages = "446--451",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Bone mass in rett syndrome

T2 - Association with clinical parameters and MECP2 mutations

AU - Shapiro, Jay

AU - Bibat, Genila M

AU - Hiremath, Girish

AU - Blue, Mary E

AU - Hundalani, Shilpa

AU - Yablonski, Theodore

AU - Kantipuly, Aditi

AU - Rohde, Charles A

AU - Johnston, Michael V

AU - Naidu, Sakkubai

PY - 2010/11

Y1 - 2010/11

N2 - Rett syndrome (RTT) is an X-linked neurodevelopmental disorder caused by mutations in the MECP2 gene. In 49 female RTT children, aged 1.9-17 y, bone mass was assessed and correlated with clinical parameters and mutations involving the MECP2 gene. We also studied five adult females, aged 20-33 y, and one male child, aged 6 y. Lumbar spine bone mineral content (BMC) and bone mineral density (BMD) were correlated with weight, height, BMI, clinical severity, degree of scoliosis, use of anticonvulsants, and ambulatory status. L1-L4 BMD and BMC showed that 48.9% of them had BMD values >2 SD below age-related norms. BMD values were in the osteoporotic range in the five adult females with RTT. Eleven percent of the children and adults with RTT experienced fractures. Low bone mass was correlated with marginal significance to clinical severity and ambulation but not to scoliosis or anticonvulsant use. Lowest bone mass occurred in patients with T158M or R270X mutations but without statistical significance. Studies in a murine model of RTT confirmed low bone mass as an inherent component of this syndrome. MECP2 mutations and clinical parameters impact bone mass in RTT, but an association with a specific mutation was not demonstrable.

AB - Rett syndrome (RTT) is an X-linked neurodevelopmental disorder caused by mutations in the MECP2 gene. In 49 female RTT children, aged 1.9-17 y, bone mass was assessed and correlated with clinical parameters and mutations involving the MECP2 gene. We also studied five adult females, aged 20-33 y, and one male child, aged 6 y. Lumbar spine bone mineral content (BMC) and bone mineral density (BMD) were correlated with weight, height, BMI, clinical severity, degree of scoliosis, use of anticonvulsants, and ambulatory status. L1-L4 BMD and BMC showed that 48.9% of them had BMD values >2 SD below age-related norms. BMD values were in the osteoporotic range in the five adult females with RTT. Eleven percent of the children and adults with RTT experienced fractures. Low bone mass was correlated with marginal significance to clinical severity and ambulation but not to scoliosis or anticonvulsant use. Lowest bone mass occurred in patients with T158M or R270X mutations but without statistical significance. Studies in a murine model of RTT confirmed low bone mass as an inherent component of this syndrome. MECP2 mutations and clinical parameters impact bone mass in RTT, but an association with a specific mutation was not demonstrable.

UR - http://www.scopus.com/inward/record.url?scp=77958495173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958495173&partnerID=8YFLogxK

U2 - 10.1203/PDR.0b013e3181f2edd2

DO - 10.1203/PDR.0b013e3181f2edd2

M3 - Article

C2 - 20661168

AN - SCOPUS:77958495173

VL - 68

SP - 446

EP - 451

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 5

ER -